Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Adaptimmune_Therapeutics
|
| gptkbp:activities |
T-cell receptor engineered T-cells
|
| gptkbp:clinical_trial |
gptkb:2020
Phase 1/2 |
| gptkbp:developed_by |
gptkb:Adaptimmune_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
ADP-A2 M4
|
| gptkbp:indication |
gptkb:healthcare_organization
|
| gptkbp:manager |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:targets |
gptkb:MAGE-A4
|
| gptkbp:type |
gptkb:drug
|